Emergent Health Corp (EMGE)
OTCMKTS · Delayed Price · Currency is USD
0.0000
-0.0003 (-99.67%)
At close: Feb 12, 2026

Emergent Health Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2021FY 2020FY 2013FY 2012FY 2011
Period Ending
Feb '26 Dec '21 Dec '20 Dec '13 Dec '12 Dec '11
033212
Market Cap Growth
-99.92%9.14%85.17%16.67%-14.29%638.96%
Enterprise Value
-32111
Last Close Price
0.000.060.070.070.060.07
PE Ratio
---13.3010.486.35
PS Ratio
0.0027.2117.831.631.012.28
PB Ratio
0.01102.879.271.681.652.17
P/TBV Ratio
--21.581.691.662.17
P/OCF Ratio
---20.92--
EV/Sales Ratio
-23.0614.860.790.411.18
EV/EBITDA Ratio
---4.142.46-
EV/EBIT Ratio
---4.152.463.35
Debt / Equity Ratio
10.6810.68---0.27
Net Debt / Equity Ratio
2.532.53-0.53-0.85-0.88-1.11
Net Debt / EBITDA Ratio
-0.44-0.443.03-4.30-3.26-
Asset Turnover
0.340.34-1.021.390.96
Inventory Turnover
0.530.53-1.765.9815.59
Quick Ratio
0.740.74-10.8310.629.08
Current Ratio
0.940.94-13.6912.999.36
Return on Equity (ROE)
-164.17%-164.17%-13.50%16.66%44.16%
Return on Assets (ROA)
-35.62%-35.62%-12.20%14.36%21.10%
Return on Invested Capital (ROIC)
-66.38%-66.38%-51.50%99.07%1649.49%390.63%
Return on Capital Employed (ROCE)
-631.00%-631.00%-23.60%19.80%27.00%26.50%
Earnings Yield
-67626.23%-8.88%-2.65%7.52%9.54%15.74%
Buyback Yield / Dilution
-235.09%-3.97%-222.30%-3.13%-7.83%-4.37%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.